Guest Blogs - Page 6 of 47 - Express Pharma

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 2

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1

Driving change: Digital innovation and the future of drug discovery in India

Role of nitric oxide in controlling genetic regulators to maintain cellular health

Small benefits, big impact: Understanding the value of novel drugs in metastatic cancer

Pharma and medtech marketing: Navigating the imminent disclosure deadline

7 common compliance issues faced by the pharmaceutical industry in India

Navigating geopolitical shifts: India’s strategic position in global pharma supply chains

Three factors to make a next-gen eCOA platform work

A defining opportunity for clarity from GS1